| Literature DB >> 33037133 |
Gerhard Liebisch1, Eoin Fahy2, Junken Aoki3, Edward A Dennis4, Thierry Durand5, Christer S Ejsing6, Maria Fedorova7, Ivo Feussner8, William J Griffiths9, Harald Köfeler10, Alfred H Merrill11, Robert C Murphy12, Valerie B O'Donnell13, Olga Oskolkova14, Shankar Subramaniam15, Michael J O Wakelam16, Friedrich Spener17.
Abstract
A comprehensive and standardized system to report class="Chemical">lipid structures analyzed by MS is essential for the communication and storage of <class="Chemical">span class="Chemical">lipidomics data. Herein, an update on both the LIPID MAPS classification system and shorthand notation of lipid structures is presented for lipid categories Fatty Acyls (FA), Glycerolipids (GL), Glycerophospholipids (GP), Sphingolipids (SP), and Sterols (ST). With its major changes, i.e., annotation of ring double bond equivalents and number of oxygens, the updated shorthand notation facilitates reporting of newly delineated oxygenated lipid species as well. For standardized reporting in lipidomics, the hierarchical architecture of shorthand notation reflects the diverse structural resolution powers provided by mass spectrometric assays. Moreover, shorthand notation is expanded beyond mammalian phyla to lipids from plant and yeast phyla. Finally, annotation of atoms is included for the use of stable isotope-labeled compounds in metabolic labeling experiments or as internal standards. This update on lipid classification, nomenclature, and shorthand annotation for lipid mass spectra is considered a standard for lipid data presentation.Entities:
Keywords: fatty acyls; glycerolipids; glycerophospholipids; lipidomics; mass spectrometry; sphingolipids; sterols
Year: 2020 PMID: 33037133 PMCID: PMC7707175 DOI: 10.1194/jlr.S120001025
Source DB: PubMed Journal: J Lipid Res ISSN: 0022-2275 Impact factor: 5.922
Fig. 1.Hierarchical scheme for the analysis of glucosylceramide. “Analysis” presents MS-data and “Annotation” the respective hierarchical levels with corresponding shorthand annotation. The chemical structure illustrates the Complete Structure level, numbers along the sphingoid base indicate conventional numbering of carbons therein.
Class abbreviations in Category FA
| Common Name | Lipid Class, LIPID MAPS | Abbreviation |
| Fatty acids | Fatty acids and conjugates [FA01] | FA |
| Fatty alcohols | Fatty alcohols [FA05] | FOH |
| Fatty aldehydes | Fatty aldehydes [FA06] | FAL |
| Acyl carnitines | Fatty acyl carnitines [FA0707] | CAR |
| Acyl CoAs | Fatty acyl CoAs [FA0705] | CoA |
| NA | ||
| NAE | ||
| NAT | ||
| Wax esters | Wax monoesters [FA0701] | WE |
| Wax diesters | Wax diesters [FA0702] | WD |
| FA estolides | FAHFA wax monoesters [FA0701] | FA-EST |
Level-dependent shorthand notation for examples of fatty acids
| Subclass | Species Level | DB-Position Level | Full Structure Level | Complete Structure Level (= Common Name) |
| Straight-chain FA | FA 12:0 | Laurate | ||
| FA 14:0 | Myristate | |||
| FA 16:0 | Palmitate | |||
| FA 16:1 | FA 16:1( | FA 16:1(9Z) | Palmitoleate | |
| FA 18:0 | Stearate | |||
| FA 18:1 | FA 18:1( | FA 18:1(9Z) | Oleate | |
| FA 18:1 | FA 18:1( | FA 18:1(11E) | ||
| FA 18:2 | FA 18:2( | FA 18:2(9Z,12Z) | Linoleate | |
| FA 18:3 | FA 18:3( | FA 18:3(9Z,12Z,15Z) | α-Linolenate | |
| FA 18:3 | FA 18:3( | FA 18:3(6Z,9Z,12Z) | γ-Linolenate | |
| FA 18:4 | FA 18:4( | FA 18:4(6Z,9Z,12Z,15Z) | Stearidonate | |
| FA 20:0 | Arachidate | |||
| FA 20:3 | FA 20:3( | FA 20:3(8Z,11Z,14Z) | ||
| FA 20:3 | FA 20:3( | FA 20:3(11Z,14Z,17Z) | ||
| FA 20:3 | FA 20:3( | FA 20:3(5Z,8Z,11Z) | Mead acid | |
| FA 20:4 | FA 20:4( | FA 20:4(5Z,8Z,11Z,14Z) | Arachidonate | |
| FA 20:5 | FA 20:5( | FA 20:5(5Z,8Z,11Z,14Z,17Z) | Eicosapentaenoate | |
| FA 22:0 | Behenate | |||
| FA 22:6 | FA 22:6( | FA 22:6(4Z,7Z,10Z,13Z,16Z,19Z) | Docosahexaenoate | |
| FA 24:0 | Lignocerate | |||
| FA 24:1 | FA 24:1( | FA 24:1(15Z) | Nervonate | |
| FA 32:5 | FA 32:5( | FA 32:5(14Z,17Z,20Z,23Z,26Z) | Dotriacontapentaenoic acid; FA 32:5(n-6) | |
| FA 34:5 | FA 34:5 ( | FA 34:5(19Z,22Z,25Z,28Z,31Z) | Tetratriacontapentaenoic acid; FA 34:5(n-3) | |
| FA 36:6 | FA 36:6( | FA 36:6(18Z,21Z,24Z,27Z,30Z,33Z) | Hexatriacontahexaenoic acid; FA 36:6(n-3) | |
| Fatty acyl ester | FA 19:0 | FA 18:0;1OMe | Methyl stearate | |
| Methyl branched | FA 20:0 | FA 16:0;3Me,7Me,11Me,15Me | FA 16:0;3Me,7Me[R],11Me[R],15Me (Phytanate) | |
| Hydroxy | FA 18:0;O | FA 18:0;9OH | FA 18:0;9OH[S] | |
| Oxo | FA 11:1;O | FA 11:0;9oxo | FA 11:0;9oxo | |
| Cyclopropane | FA 19:1 | FA 19:0;[11-13cy3:0] | Lactobacillic acid | |
| Cyclopropene | FA 19:2 | FA 19:0;[9-11cy3:1( | Sterculic acid | |
| Cyclopentene | FA 18:3 | FA 18:1(6Z);[14-18cy5:1( | Gorlic acid |
Uncharged molecular mass measured by low resolution MS of corresponding m/z from carboxylate anion (electrospray ionization) or molecular ion species (radical cation by EI).
Annotation based on the assumption of a straight-chain fatty acyl plus functional groups based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion.
Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).
Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatization and GC/MS or specific product ions in a MS/MS experiment.
Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic based separation of potential isomers (GC or HPLC).
Level-dependent shorthand notation for examples of fatty aldehydes, esters, and amides
| Subclass | Species Level | Molecular Species Level | DB-Position Level | Full Structure Level | Complete Structure Level (= Common Name) |
| Fatty aldehyde | FAL 9:1;O | FAL 9:1;O | FAL 9:1(2);OH | FAL 9:1(2E);4OH | 4-Hydroxynonenal |
| Wax ester | WE 32:1 | WE 14:0/18:1 | WE 14:0/18:1(9) | WE 14:0/18:1(9Z) | WE 14:0/18:1(9Z) |
| Alkyl acetates | WE 20:3 | WE 18:3/2:0 | WE 18:3(9,12,15)/2:0 | WE 18:3(9Z,12Z,15Z)/2:0 | WE 18:3(9Z,12Z,15Z)/2:0 |
| Wax diester | WD 42:0 | WD 22:0/FA 10:0_FA 10:0 | WD 22:0/FA 10:0_FA 10:0 | WD 22:0;2O(FA 10:0),3O(FA 10:0) | WD 22:0;2O(FA 10:0[S]),3O(FA 10:0[R]) |
| NA 24:4 | NA 4:0/20:4 | NA 4:0/20:4(5,8,11,14) | NA 4:0/20:4(5Z,8Z,11Z,14Z) | NA 4:0/20:4(5Z,8Z,11Z,14Z) | |
| NAE 18:2 | NAE 18:2 | NAE 18:2(9,12) | NAE 18:2(9Z,12Z) | NAE 18:2(9Z,12Z), anandamide 18:2(n-6) | |
| Fatty acyl estolides (FA-EST) | FAHFA 36:1;O | FAHFA 18:1/18:0;O | FAHFA 18:1(9)/18:0;O | FAHFA 18:1(9Z)/9O(FA 18:0) | FAHFA 18:1(9Z)/9O(FA 18:0[R]) |
Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).
Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatization and GC/MS or specific product ions in a MS/MS experiment.
Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic based separation of potential isomers (GC or HPLC).
In shorthand notation for wax monoesters (WE), wax diesters (WD), and fatty amides (NA, NAE), alcohol and amine moieties precede the fatty acyl moiety.
Parent polyunsaturated fatty acids and oxygenated product specialized pro-resolving mediators
| Fatty Acid | Product Class | Complete Structure Level (= Common Name) |
| Arachidonic acid; AA(n-6) | Eicosanoid | Lipoxin A4, lipoxin B4 |
| Eicosapentaenoic acid; EPA(n-3) | Eicosanoid | Resolvin E1, E2, E3 |
| Docosahexaenoic acid; DHA(n-3) | Docosanoid | Resolvin D1, D2, D3, D4, D5, D6 |
| Docosapentaenoic acid; DPA(n-3) | Docosanoid | Resolvin T1, T2, T3, T4 |
| Docosahexaenoic acid; DHA(n-3) | Docosanoid | PCTR1, PCTR2, PCTR3, protectin D1/neuroprotectin D1 |
| Docosahexaenoic acid; DHA(n-3) | Docosanoid | MCTR1, 2, 3, maresins 1, 2 |
| Docosahexaenoic acid; DHA(n-3) | Docosanoid | Protectin DX |
| Dotriacontahexaenoic acid; FA 32:6(n-3) | Dotriacontanoid | Elovanoid ELV-N32 |
| Tetratriacontahexaenoic acid; FA 34:6(n-3) | Tetratriacontanoid | Elovanoid ELV-N34 |
Parent polyunsaturated fatty acids and oxygenated product isoprostanoids
| Fatty Acid | Product Class | Complete Structure Level (= Common Name) |
| α-Linoleic acid; ALA(n-3) | Octadecanoid | F1-PhytoP |
| γ-Linolenic acid; GLA(n-6) | Octadecanoid | F1-PhytoPGLA |
| Arachidonic acid; AA(n-6) | Eicosanoid | F2-IsoP |
| Eicosapentaenoic acid; EPA(n-3) | Eicosanoid | F3-IsoP |
| Adrenic acid; AdA(n-6) | Docosanoid | F2-IsoPAdA |
| Docosapentaenoic acid; DPA(n-6) | Docosanoid | F3-NeuroPDPA(n-6) |
| Docosapentaenoic acid; DPA(n-3) | Docosanoid | F3-NeuroPDPA(n-3) |
| Docosahexaenoic acid; DHA(n-3) | Docosanoid | F4-NeuroP |
| FA 22:4(4Z,7Z,10Z,18E);[13-17cy5;14OH,16OH];20OH |
Shorthand notations for acyclic oxylipins at appropriate levels of annotation in lipidomic studies
| Species Level | DB-Position Level | Structure Defined Level | Full Structure Level | Complete Structure Level (= Common Name) |
| FA 18:2;O | FA 18:2(9,11);O | FA 18:2;OH | FA 18:2(9Z,11E);13OH | 13R-HODE, 13S-HODE |
| FA 20:4;O | FA 20:4(6,8,11,14);O | FA 20:4;OH | FA 20:4(6E,8Z,11Z,14Z);5OH | 5R-HETE, 5S-HETE |
| FA 20:4;O | FA 20:4(5,8,10,14);O | FA 20:4;OH | FA 20:4(5Z,8Z,10E,14Z);12OH | 12R-HETE, 12S-HETE |
| FA 20:4;O | FA 20:4(5,8,11,13);O | FA 20:4;OH | FA 20:4 (5Z,8Z,11Z,13E);15OH | 15R-HETE, 15S-HETE |
| FA 20:4;O2 | FA 20:4(6,8,10,14);O2 | FA 20:4;(OH)2 | FA 20:4(6Z,8E,10E,14Z);5OH,12OH | LTB4 (5S,12R) |
| FA 20:5;O3 | FA 20:5(6,8,11,14,16);O3 | FA 20:5;OOH;OH | FA 20:5(6E,8Z,11Z,14Z,16E);5OOH;18OH | 5S-Hp-18S-HEPE |
| FA 20:5;O3 | FA 20:5(6,8,10,14,16);O3 | FA 20:5;(OH)3 | FA 20:5(6Z,8E,10E,14Z,16E);5OH,12OH,18OH | Resolvin E1 (5S,12R,18R) |
| FA 22:6;O3 | FA 22:6(4,8,10,12,14,19);O3 | FA 22:6;(OH)3 | FA 22:6(4Z,8E,10Z,12E,14E,19Z);7OH,16OH,17OH | Resolvin D2 (7S,16R,17S) |
| FA 22:6;O2 | FA 22:6(4,8,10,12,16,19);O2 | FA 22:6;(OH)2 | FA 22:6(4Z,8E,10E,12E,16Z,19Z);7OH,14OH | Maresin 1 (7R,14S) |
Uncharged molecular mass measured by low resolution MS of corresponding m/z from carboxylate anion (electrospray ionization) or molecular ion species (radical cation by EI).
Annotation based on the assumption of a straight-chain fatty acyl plus functional groups based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion.
Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).
Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatization and GC/MS or specific product ions in a MS/MS experiment.
Common shorthand accepted by IUPAC (23).
Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic based separation of potential isomers (GC or HPLC).
Shorthand notations for cyclic oxylipins at appropriate levels of annotation in lipidomic studies
| Species Level | Structure Defined Level | Full Structure Level | Complete Structure Level (= Common Name) |
| FA 20:4;O3 | FA 20:3;(OH)2;oxo | FA 20:2(5Z,13E);[8-12cy5;11OH;9oxo];15OH | PGE2 |
| FA 20:4;O3 | FA 20:3;(OH)2;oxo | FA 20:2(5Z,13E);[8-12cy5;9OH;11oxo];15OH | PGD2 |
| FA 20:3;O3 | FA 20:3;(OH)3 | FA 20:2(5Z,13E);[8-12cy5;9OH,11OH];15OH | PGF2α |
| FA 20:3;O3 | FA 20:2;(OH)2;oxo | FA 20:1(13E);[8-12cy5;11OH;9oxo];15OH | 8-iso-PGE1 |
| FA 20:3;O4 | FA 20:2;(OH)3;oxo | FA 20:1(13E);[8-12cy5;9OH,11OH];15OH;6oxo | 6-oxo-PGF1α |
| FA 20:3;O4 | FA 20:3;(OH)3;oxy | FA 20:2(5Z,13E);[8-13cy6;9OH,11OH);11oxy];15OH | TXB2 |
| FA 22:5;O3 | FA 22:5;(OH)3 | FA 22:4(4Z,7Z,10Z,18E);[13-17cy5;14OH,16OH];20OH | 20-F4-NeuroP |
Uncharged molecular mass measured by low resolution MS of corresponding m/z from carboxylate anion (electrospray ionization) or molecular ion species (radical cation by EI).
Annotation based on the assumption of a straight-chain fatty acyl plus functional groups based on exact mass measurements using a high-resolution mass spectrometer of fatty acyl indicating ion.
Shorthand notation applies only when exact location and nature of functional group(s) are determined by specific fragment ions obtained by derivatization and GC/MS or specific product ions in a MS/MS experiment.
Common shorthand accepted by IUPAC (23).
Validated assay is required to employ trivial names that engages appropriate internal standard, proper assessment of signal-to-noise, and a chromatographic based separation of potential isomers (GC or HPLC).
Class abbreviations in Category GL
| Common Name | Lipid Class, LIPID MAPS | Abbreviation |
| Monoacyl/alkylglycerides (monoglycerides) | Monoradylglycerols [GL01] | MG |
| Diacyl/alkylglycerides (diglycerides) | Diradylglycerols [GL02] | DG |
| Triacyl/alkylglycerides (triglycerides) | Triradylglycerols [GL03] | TG |
| Estolides | Estolides [GL0305] | TG-EST |
| Sulfoquinovosylmonoacylglycerols | Glycosylmonoacylglycerols [GL0401] | SQMG |
| Monogalactosylmonoacylglycerol | Glycosylmonoacylglycerols [GL0401] | MGMG |
| Digalactosylmonoacylglycerol | Glycosylmonoacylglycerols [GL0401] | DGMG |
| Sulfoquinovosyldiacylglycerols | Glycosyldiacylglycerols [GL0501] | SQDG |
| Monogalactosyldiacylglycerol | Glycosyldiacylglycerols [GL0501] | MGDG |
| Digalactosyldiacylglycerol | Glycosyldiacylglycerols [GL0501] | DGDG |
Examples for shorthand notation of glycerolipids
| Bond Type | Species Level | Molecular Species Level | Full Structure Level | |
| Acyl | MG 18:0 | MG 18:0 | MG 0:0/18:0/0:0 | |
| Alkyl | MG O-18:0 | MG O-18:0 | MG 0:0/O-18:0/0:0 | |
| Diacyl | DG 34:1 | DG 16:0_18:1 | DG 16:0/18:1/0:0 | DG 16:0/18:1(9Z)/0:0 |
| Acyl-alkyl | DG O-34:1 | DG O-16:0_18:1 | DG O-16:0/18:1/0:0 | DG O-16:0/18:1(9Z)/0:0 |
| Dialkyl | DG dO-32:1 | DG O-16:0_O-16:1 | DG O-16:0/O-16:1/0:0 | DG O-16:0/O-16:1(9Z)/0:0 |
| DG 30:1 | ||||
| Triacyl | TG 52:2 | TG 16:0_18:1_18:1 | TG 16:0/18:1/18:1 | TG 16:0/18:1(9Z)/18:1(11Z) |
| TG 16:0_36:2 (only one acyl chain identified) | TG 16:0_18:1(sn-2)_18:1 | |||
| Acyl-alkyl | TG O-52:2 | TG O-16:0_18:1_18:1 | TG O-16:0/18:1/18:1 | TG O-16:0/18:1(9Z)/18:1(11Z) |
| TG 51:2 | ||||
| Acyl-dialkyl | TG dO-52:2 | TG O-18:1_O-16:0_18:1 | TG O-18:1/O-16:0/18:1 | TG O-18:1(9Z)/O-16:0/18:1(9Z) |
| TG 50:2 | ||||
| Trialkyl | TG tO-52:2 | TG O-18:1_O-16:0_O-18:1 | TG O-18:1/O-16:0/O-18:1 | TG O-18:1(9Z)/O-16:0/O-18:1(9Z) |
| TG 49:2 | ||||
| TG-Estolide | TG 68:3;O2 | TG 18:1_18:1_32:1;O2 | TG 16:0;O(FA 16:0)/18:1/18:1 | TG 16:0;5O(FA 16:0)/18:1(9Z)/18:1(9Z) |
Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species.
Annotation requires MS/MS and detection of FA chain-specific fragments.
-Positions determined by specific analysis like differential mobility spectrometry (32), LC separation of isomeric species using silver ions (33).
DB-positions determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).
Annotation using low-resolution MS including the assumption of acyl chains only.
Only acyl-chain at sn-2-position is defined.
Examples for shorthand notation of phospho- and lysophospholipids containing ester and/or ether bonds
| Bond Type | Species Level | Molecular SPECIES Level | Full Structure Level | |
| Diacyl | BMP 34:1 | BMP 16:0_18:1 | BMP 16:0/0:0/18:1/0:0 | BMP 16:0/0:0/18:1(9Z)/0:0 |
| Tetraacyl | CL 72:7 | CL 18:1_18:2_18:2_18:2 | CL 18:1/18:2/18:2/18:2 | CL 18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)18:2(9Z,12Z) |
| CL 18:1_54:6 (only one acyl chain identified) | ||||
| CL 36:3_36:4 (known DG fragments) | ||||
| Tetra-alkyl | CL eO-80:0 | CL O-20:0/O-20:0/O-20:0/O-20:0 | CL O-20:0/O-20:0/O-20:0/O-20:0 | CL O-16:0(3Me,7Me,11Me,15Me)/O-16:0(3Me,7Me,11Me,15Me)/O-16:0(3Me,7Me,11Me,15Me)/O-16:0(3Me,7Me,11Me,15Me) |
| Diacyl | PC 34:1 | PC 16:0_18:1 | PC 16:0/18:1 | PC 16:0/18:1(9Z) |
| Alkyl | PC O-34:1 | PC O-16:0_18:1 | PC O-16:0/18:1 | PC O-16:0/18:1(9Z) |
| Dialkyl | PC dO-34:1 | PC O-16:0_O-18:1 | PC O-16:0/O-18:1 | PC O-16:0/O-18:1(9Z) |
| Diacyl | PE 34:1 | PE 16:0_18:1 | PE 16:0/18:1 | PE 16:0/18:1(9Z) |
| Plasmalogen | PE O-34:2 | PE P-16:0/18:1 | PE P-16:0/18:1(9Z) | |
| Triacyl | LCL 54:5 | LCL 18:1_18:2_18:2 | LCL 18:1/18:2/18:2/0:0 | LCL 18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/0:0 |
| Monoacyl | LPC 16:0 | LPC 16:0 | LPC 16:0/0:0 | LPC 16:0/0:0 |
| Monoalkyl | LPC O-16:0 | LPC O-16:0 | LPC O-16:0/0:0 | LPC O-16:0/0:0 |
Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species.
Annotation requires MS/MS and detection of FA chain specific fragments.
sn-Positions determined by specific MS analysis like differential mobility spectrometry (34).
Positions of DBs determined by independent techniques such as ozonolysis (8) or photochemical derivatization (9).
Annotation using low resolution MS, QQQ and +PIS m/z 184 requires the assumption of even numbered carbon chains only.
Annotation using low resolution MS, QQQ and +NL 141 requires the assumption of even numbered carbon chains only.
Identification of plasmalogens (alk-1-enyl bond) require specific MS analysis (35).
Class abbreviations in Category GP
| Common Name | Lipid Class, LIPID MAPS | Abbreviation |
| Bis[monoacylglycero]phosphates | Monoacylglycerophosphomonoradylglycerols [GP0410] | BMP |
| Cardiolipins | Glycerophosphoglycerophosphoglycerols [GP12] | CL |
| Phosphatidic acids | Glycerophosphates [GP10] | PA |
| Phosphatidylcholines | Glycerophosphocholines [GP01] | PC |
| Phosphatidylethanolamines | Glycerophosphoethanolamines [GP02] | PE |
| Phosphatidylgylcerols | Glycerophosphoglycerols [GP04] | PG |
| Phosphatidylgylcerolphosphates | Glycerophosphoglycerophosphates [GP05] | PGP |
| Phosphatidylinositols | Glycerophosphoinositols [GP06] | PI |
| Phosphatidylserines | Glycerophosphoserines [GP03] | PS |
| Lysophospholipids | Prefix L | |
| Phosphatidylinositol-mannoside | PIM | |
| Subclasses phosphatidylinositol phosphates | ||
| Phosphatidylinositol-monophosphates | Glycerophosphoinositol monophosphates [GP07] | PIP |
| Phosphatidylinositol-3-phosphates | Glycerophosphoinositol monophosphates [GP07] | PIP(3′) |
| Phosphatidylinositol-4-phosphates | Glycerophosphoinositol monophosphates [GP07] | PIP(4′) |
| Phosphatidylinositol-5-phosphates | Glycerophosphoinositol monophosphates [GP07] | PIP(5′) |
| Phosphatidylinositol-bisphosphates | Glycerophosphoinositol bisphosphates [GP08] | PIP2 |
| Phosphatidylinositol-3,4-bisphosphates | Glycerophosphoinositol bisphosphates [GP08] | PIP2(3′,4′) |
| Phosphatidylinositol-3,5-bisphosphates | Glycerophosphoinositol bisphosphates [GP08] | PIP2(3′,5′) |
| Phosphatidylinositol-4,5-bisphosphates | Glycerophosphoinositol bisphosphates [GP08] | PIP2(4′,5′) |
| Phosphatidylinositol-trisphosphates | Glycerophosphoinositol trisphosphates [GP09] | PIP3 |
| | PS-N(Alk) | |
| | PS-N(FA) | |
| Phosphatidylserine-carboxyalkylpyrroles | PS-CAP | |
| Phosphatidylserine-malondialdehydes | PS-MDA | |
| | PE-N(Alk) | |
| | PE-N(FA) | |
| Phosphatidylethanolamine-carboxyalkylpyrroles | PE-CAP | |
| Phosphatidylethanolamine-glucosides | PE-Glc | |
| Phosphatidylethanolamine-glucuronides | PE-GlcA | |
| Phosphatidylethanolamine-α-ketoglucoside | PE-GlcK | |
| Phosphatidylethanolamine-carboxymethylates | PE-CM | |
| Phosphatidylethanolamine-carboxyethylates | PE-CE | |
| Phosphatidylethanolamine-formamides | PE-FA | |
| Phosphatidylethanolamine-carbamides | PE-CA | |
| Phosphatidyethanolamine- malondialdehydes | PE-MDA | |
| Phosphatidylethanolamine-hydroxynonenals | PE-HNE | |
| Phosphatidylethanolamine-isolevuglandins | PE-isoLG |
Examples for shorthand notation of phosphatidylinositol phosphates
| Bond Type | Species Level | Phosphate Position Level | Molecular Species Level | Full Structure Level | |
| Diacyl | PIP 36:1 | PIP(3′) 36:1 | PIP(3′) 16:0_18:1 | PIP(3′) 16:0/18:1 | PIP(3′) 16:0/18:1(9Z) |
| Diacyl | PIP2 38:4 | PIP2(4′,5′) 38:4 | PIP2(4′,5′) 18:0_20:4 | PIP2(4′,5′) 18:0/20:4 | PIP2(4′,5′) 18:0/20:4(4Z,8Z,11Z,14Z) |
Examples for shorthand notation of N-modified phospholipids
| Oxidative Modification | Species Level | Molecular Species Level | Full Structure Level | |
| PS-N(Alk) 40:3 | PS-N(6:0)16:0_18:3 | PS-N(6:0) 16:0/18:3 | PS-N(6:0) 16:0/18:3(9Z,12Z,15Z) | |
| PE-N(FA) 54:5 | PE-N(FA 18:1) 16:0_20:4 | PE-N(FA 18:1) 16:0/20:4 | PE-N(FA 18:1(9Z)) 16:0/20:4(4Z,8Z,11Z,14Z) | |
| Hydroxynonenal adduct | PE-HNE 36:4 | PE-HNE 16:0_20:4 | PE-HNE 16:0/20:4 | PE-HNE 16:0/20:4(4Z,8Z,11Z,14Z) |
Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species.
Annotation requires MS/MS and detection of FA chain specific fragments.
sn-Positions determined by specific MS analysis like differential mobility spectrometry (34).
Examples for shorthand notation of OxPLs
| Oxidative Modification | Species Level | Molecular Species Level | Structure Defined Level | Full Structure Level | |
| Hydroxylation | PC 36:4;O | PC 16:0_20:4;O | PC 16:0/20:4;O | PC 16:0/20:4;OH | PC 16:0/20:4(5Z,8Z,10E,14Z);12OH |
| PC 34:1;O2 | PC 16:0_18:1;O2 | PC 16:0/18:1;O2 | PC 16:0/18:1;(OH)2 | PC 16:0/18:1(9Z);12OH,13OH | |
| Epoxide | PC 34:2;O | PC 16:0_18:2;O | PC 16:0/18:2;O | PC 16:0/18:1;Ep | PC 16:0/18:1(9Z);12Ep |
| Hydroperoxide | PC 34:2;O2 | PC 16:0_18:2;O2 | PC 16:0/18:2;O2 | PC 16:0/18:2;OOH | PC 16:0/18:2(9Z,11E);13OOH |
| Peroxide | PC 34:2;O2 | PC 16:0_18:2;O2 | PC 16:0/18:2;O2 | PC 16:0/18:1;OO | PC 16:0/18:1(9Z);12OO |
| Aldehyde | PC 21:1;O | PC 16:0_5:1;O | PC 16:0/5:1;O | PC 16:0/5:0;oxo | PC 16:0/5:0;5oxo |
| Carboxylic acid | PC 25:1;O2 | PC 16:0_9:1;O2 | PC 16:0/9:1;O2 | PC 16:0/9:0;COOH | PC 16:0/9:0;8COOH |
| Hydroxy-aldehyde | PC 26:3;O2 | PC 18:1_8:2;O2 | PC 18:1/8:2;O2 | PC 18:1/8:1;OH;oxo | PC 18:1(9Z)/8:1(6E);5OH;8oxo |
| PC | PC 36:4;O3 | PC 16:0_20:4;O3 | PC 16:0/20:4;O3 | PC 16:0/20:2;[cy5;OH;oxo];OH | PC 16:0/20:2(5Z,13E);[8-12cy5;11OH;9oxo];15OH (common name 8-IsoPGE2-PC) |
Annotation based on exact mass measurements using a high-resolution mass spectrometer, which allows differentiation of isobaric acyl and alkyl species.
Annotation requires MS/MS and detection of FA chain specific fragments.
sn-Positions determined by specific MS analysis like differential mobility spectrometry (34).
Class abbreviations in Category SP
| Common Name | Lipid Class, LIPID MAPS | Abbreviation |
| Sphingoid bases | Sphingoid bases [SP01] | SPB |
| Sphingoid base-phosphates | Sphingoid bases [SP0105] | SPBP |
| Ceramides | Ceramides [SP02] | Cer |
| Ceramide-phosphates | Ceramide phosphates [SP0205] | CerP |
| Acyl Ceramides | Acylceramides [SP0204] | ACer |
| Sphingomyelins | Phosphosphingolipids [SP03] | SM |
| Hexosylceramides | Neutral glycosphingolipids [SP05] | HexCer |
| Glucosylceramide | Neutral glycosphingolipids [SP05] | GlcCer |
| Galactosylceramide | Neutral glycosphingolipids [SP05] | GalCer |
| Dihexosylceramides | Neutral glycosphingolipids [SP05] | Hex2Cer |
| Lactosylceramide | Neutral glycosphingolipids [SP05] | LacCer |
| Sulfatides | Sulfoglycosphingolipids (sulfatides) [SP0602] | SHexCer |
| Inositolphosphorylceramides | Ceramide phosphoinositols [SP0303] | IPC (PI-Cer) |
| Ethanolaminephosphorylceramides | Ceramide phosphoethanolamines [SP0302] | EPC (PE-Cer) |
| Glycosylinositolphosphorylceramides | Ceramide phosphoinositols [SP0303] | GIPC |
| Mannosyl-inositolphosphoceramides | Ceramide phosphoinositols [SP0303] | MIPC |
| Mannosyl-diinositolphosphoceramide | Ceramide phosphoinositols [SP0303] | M(IP)2C |
Examples for shorthand notation of sphingolipids with a free amino group
| Sphingoid Base | Species Level | Structure Defined Level | Full Structure Level |
| Sphingosine | SPB 18:1;O2 | SPB 18:1;(OH)2 | SPB 18:1(4E);1OH,3OH |
| 3-Keto-sphinganine | SPB 18:1;O2 | SPB 18:0;OH;oxo | SPB 18:0;1OH;3oxo |
| Sphinganine | SPB 18:0;O2 | SPB 18:0;(OH)2 | SPB 18:0;1OH,3OH |
| Sphingadiene | SPB 18:2;O2 | SPB 18:2;(OH)2 | SPB 18:2(4E,14Z);1OH,3OH |
| Phytosphingosine | SPB 18:0;O3 | SPB 18:0;(OH)3 | SPB 18:0;1OH,3OH,4OH |
| C20-sphingosine | SPB 20:1;O2 | SPB 20:1;(OH)2 | SPB 20:1(4E);1OH,3OH |
| Sphingosine-1-phosphate | SPBP 18:1;O2 | SPBP 18:1;OH | SPBP(1) 18:1(4E);3OH |
| Sphinganine-1-phosphate | SPBP 18:0;O2 | SPBP 18:0;OH | SPBP(1) 18:0;3OH |
| 1-Deoxymethyl-sphinganine | SPB 17:0;O | SPB 17:0;OH | SPB 17:0;2OH |
| 1-Deoxy-sphinganine | SPB 18:0;O | SPB 18:0;OH | SPB 18:0;3OH |
| Lysoinositolphosphorylceramides | LIPC 18:0;O3 | LIPC 18:0;(OH)2 | LIPC(1) 18:0;3OH,4OH |
| Lysosphingomyelin | LSM 18:1;O2 | LSM 18:1;OH | LSM(1) 18:1(4E);3OH |
Annotation based on exact mass measurements using a high-resolution mass spectrometer.
Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9).
Examples for shorthand notation of sphingolipids containing an amide bound fatty acid
| Phyla | Species Level | Molecular Species Level | Full Structure Level |
| Mammalian | Cer 34:1;O2 | Cer 18:1;O2/16:0 | Cer 18:1(4E);1OH,3OH/16:0 |
| Mammalian | Cer 34:0;O2 | Cer 18:0;O2/16:0 | Cer 18:0;1OH,3OH/16:0 |
| Mammalian | ACer 58:1;O2 | FA 24:1-ACer 18:1;O2/16:0 | FA 24:1-ACer(1) 18:1(4E);3OH/16:0 |
| Mammalian | CerP 34:1;O2 | CerP 18:1;O2/16:0 | CerP(1) 18:1(4E);3OH/16:0 |
| Mammalian | SM 36:2;O2 | SM 18:2;O2/18:0 | SM(1) 18:2(4E,14Z);3OH/18:0 |
| Mammalian | SM 44:2;O2 | SM 20:1;O2/24:1 | SM(1) 20:1(4E);3OH/24:1(15Z) |
| Mammalian | Cer 62:3;O4 | Cer 18:1;O2/26:0;O(FA 18:1) | Cer 18:1(4E);1OH,3OH/26:0;26O(FA 18:1(9Z)) |
| Cer 18:1;O2/44:2;O2 | |||
| Plant | IPC 42:1;O4 | IPC 18:1;O3/24:0;O | IPC(1) 18:1(8E);3OH,4OH/24:0;2OH |
| Yeast | Cer 44:0;O5 | Cer 18:0;3O/26:0;O2 | Cer 18:0;1OH,3OH,4OH/26:0;2OH,3OH |
Annotation based on exact mass measurements using a high-resolution mass spectrometer.
Annotation requires MS/MS enabling detection of sphingoid base and/or N-linked FA.
Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9).
Annotation using low resolution MS QQQ and a PIS m/z 184 requires the assumption of a sphingoid base with two hydroxyl groups.
Annotation with structural characterization of O-acyl in N-linked acyl chain.
Annotation without structural differentiation of N-linked acyl chain.
Examples for shorthand notation of glycosphingolipids containing an amide bound fatty acid
| Phyla | Species Level | Molecular Species Level | Full Structure Level |
| Mammalian | Hex-Cer 34:1;O2 | Hex-Cer 18:1;O2/16:0 | Glc-Cer(1) 18:1(4E);3OH/16:0 (see also |
| Glc-Cer 18:1;O2/16:0 | |||
| Mammalian | Hex-Cer 34:0;O2 | Hex-Cer 18:0;O2/16:0 | Gal-Cer(1) 18:0;3OH/16:0 |
| Gal-Cer 18:0;O2/16:0 | |||
| Mammalian | Hex2Cer 34:1;O2 | Hex2Cer 18:1;O2/16:0 | Lac-Cer(1) 18:1(4E);3OH/16:0 |
| Gal-Glc-Cer(1) 18:1(4E);3OH/16:0 | |||
| Mammalian | Hex3Cer 42:1;O2 | Hex3Cer 18:1;O2/24:0 | Gal-Gal-Glc-Cer(1) 18:1(4E);3OH/24:0 (= Gb3) |
| Mammalian | NeuAcHex2Cer 42:1;O2 | NeuAcHex2Cer 18:1;O2/24:0 | NeuAc-Gal-Glc-Cer(1) 18:1(4E);3OH/24:0 (= GM3) |
| Mammalian | NeuAc2Hex2Cer 42:1;O2 | NeuAc2Hex2Cer 18:1;O2/24:0 | NeuAc-NeuAc-Gal-Glc-Cer(1) 18:1(4E);3OH/24:0 (= GD3) |
| Mammalian | SHex-Cer 34:1;O2 | SHex-Cer 18:1;O2/16:0 | S(3′)Hex-Cer(1) 18:1(4E);3OH/16:0 |
| S(3′)Gal-Cer(1) 18:1(4E);3OH/16:0 | |||
| Mammalian | SHexHexNAcHex3Cer 34:1;O2 | SHexHexNAcHex3Cer 18:1;O2/16:0 | S(3′)Hex-HexNac-Hex-Hex-Hex-Cer(1) 18:1(4E);3OH/16:0 |
| S(3′)Gal-GalNAc-Gal-Gal-Glc-Cer(1) 18:1(4E);3OH/16:0 | |||
| Plant | HexA-IPC 42:1;O4 | HexA-IPC 18:1;O3/24:0;O | GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH |
| Plant | HexHexA-IPC 42:1;O4 | Hex-HexA-IPC 18:1;O3/24:0;O | Glc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH |
| Plant | HexAHexNAc-IPC 42:1;O4 | HexNAc-HexA-IPC 18:1;O3/24:0;O | GlcNAc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH |
| Plant | HexHexAHexNAc-IPC 42:1;O4 | Hex-HexNAc-HexA-IPC 18:1;O3/24:0;O | Glc-GlcNAc-GlcA-IPC(1) 18:1(8E);3OH,4OH/24:0;2OH |
| Yeast | MIPC 44:0;O4 | MIPC 18:0;O3/26:0;O | MIPC(1) 18:0;3OH,4OH/26:0;2OH |
| Yeast | M(IP)2C 46:0;O4 | M(IP)2C 20:0;O3/26:0;O | M(IP)2C(1) 20:0;3OH,4OH/26:0;2OH |
Annotation based on exact mass measurements using a high-resolution mass spectrometer.
Annotation requires MS/MS enabling detection of sphingoid base and/or N-linked FA.
Positions of functional groups and DBs determined by independent techniques such as chromatographic resolution, ozonolysis (8) or photochemical derivatization (9).
Separation of isomeric hexosylceramide by HILIC (36).
Annotation requires separation of stereoisomers at glycosidic linkage (α/β).
Abbreviations of cyclic structures
| Cyclic Structures | Abbreviation |
| Cyclopropyl | cy3 |
| Cyclopropenyl | cy3:1 |
| Cyclobutyl | cy4 |
| Cyclopentyl | cy5 |
| Cyclohexyl | cy6 |
Abbreviations of functional groups/side chains
| Functional Group/Side Chain | Abbreviation |
| Ethyl branch | Et |
| Methyl branch | Me |
| Bromo | Br |
| Chloro | Cl |
| Fluoro | F |
| Iodo | I |
| Nitro | NO2 |
| Epoxy | Ep |
| Peroxy | OO |
| Methoxy | OMe |
| Alkoxy (ether) | oxy |
| Amino | NH2 |
| Hydroperoxy | OOH |
| Sulfanyl | SH |
| hydroxy | OH |
| Oxo (keto/aldehyde; depending on position) | oxo |
| Cyano | CN |
| Phosphate | P |
| Sulfate | S |
| Carboxylic acid | COOH |
| Glycine | G |
| Taurine | T |
The order of functional groups aligns with IUPAC hierarchy (14).
Class abbreviations in Category ST
| Common Name | Lipid Class, LIPID MAPS | Abbreviation |
| Sterols | Sterols [ST01] | ST |
| Sterol esters | Sterol esters [ST0102] | SE |
| Bile acids | Bile acids and derivatives [ST04] | BA |
| Free cholesterol = cholesterol | FC | |
| Cholesteryl ester | Cholesteryl esters [ST0102] | CE |
| Sterylglycosides | Sterylglycosides | SG |
| Acylsterylglycosides | Monoradylglycosterols | ASG |
Examples of shorthand notation for sterols
| Lipid Class | Species Level | Full Structure Level | Complete Structure Level (= Common Name) |
| ST (FC) | ST 27:1;O | ST 27:1(5Z);3bOH = FC | Cholesterol |
| ST | ST 27:1;O | ST 27:1(7);5aH;3bOH | Lathosterol |
| ST | ST 28:3;O | ST 28:3(5Z,7Z,22E);24Me[R];3bOH | Ergosterol |
| ST | ST 27:2;O3 | ST 27:1(5Z);3bOH;26COOH[25R] | 3β-Hydroxycholest-5-en-(25R)26-oic acid |
| SE | SE 27:1/16:0 | CE 16:0 | Cholesteryl palmitate |
| SE | SE 27:1/18:2 | CE 18:2(9Z,12Z) | Cholesteryl linoleate |
| SE | SE 27:2/18:1 | SE 27:2(8E,24);5aH/18:1(9Z) | Zymosteryl oleate |
| ST | ST 21:3;O2 | ST 21:1(4Z);3oxo,20oxo | Progesterone |
| ST | ST 19:2;O2 | ST 19:1(4Z);17bOH;3oxo | Testosterone |
| ST | ST 19:2;O2 | ST 19:1(5Z);3bOH;17oxo | Dehydroepiandrosterone |
| ST | ST 18:3;O2 | ST 18:3(1,3,5);3OH,17bOH | 17β-Estradiol |
| ST | ST 19:2;O2;S | ST 19:1(5Z);3bS;17oxo | Dehydroepiandrosterone sulfate |
| BA | ST 24:1;O5 | BA 24:0;5bH;3aOH,7aOH,12aOH;24COOH | Cholic acid (CA) |
| BA | ST 24:1;O3 | BA 24:0;5bH;3aOH;24COOH | Lithocholic acid (LCA) |
| BA | BA 24:1;O5;T | BA 24:0;5bH;3aOH,7aOH,12aOH;24COT | Taurocholic acid (TCA) |
| BA | BA 24:1;O4;G | BA 24:0;5bH;3aOH,7aOH;24COG | Glycochenodeoxycholic acid (GCDCA) |
| BA | ST 24:1;O4;HexNAc | BA 24:0;5bH;3aOH,7bOGlcNAc;24COOH | Ursodeoxycholic acid 7β- |
| SG | SG 27:1;O;Hex | SG 27:1(5Z);3bOGlc | Cholesteryl glucoside |
| ASG | ASG 29:2;O;Glc;FA20:3 | ASG 29:2(5Z,22E);24Et[S];3bOGlc;6O(FA 20:3) | 20:3(11Z,14Z,17Z)-Glc-stigmasterol |
Abbreviations of carbohydrate structures
| Carbohydrate Structures | Abbreviation |
| Hexose | Hex |
| Galactose | Gal |
| Glucose | Glc |
| Mannose | Man |
| Neuraminic acid | Neu |
| HexNAc | |
| GalNAc | |
| GlcNAc | |
| NeuAc | |
| NeuGc | |
| Keto-deoxy-glycero-galacto-nononic acid | Kdn |
| Glucuronic acid | GlcA |
| Xylose | Xyl |
| Fucose | Fuc |
Glycan annotation is based on IUPAC-approved abbreviations (https://www.ncbi.nlm.nih.gov/glycans/snfg.html) (15).